PRESS RELEASES

[flexy_breadcrumb]

SHOULD INFANT AND FOLLOW-ON FORMULA CONTAIN ARACHIDONIC ACID?

EAP RARE DISEASES WG AT THE 2019 EAP CONGRESS AND MASTERCOURSE – SESSION ON GENETICS

EAP LETTER TO EPSCO COUNCIL AND EU HEALTH COMMISSIONER VYTENIS ANDRIUKAITIS ON HEALTH GUIDELINES FOR MIGRANT CHILDREN IN EUROPE

LETTER TO THE EUROPEAN COMMISSION ON MEDICINES SHORTAGES

EAP CALLS FOR EU GOVERNMENTS TO SAVE EUROPEAN CHILDREN FROM SYRIAN REFUGEE CAMPS

RARE DISEASES THE CHILD AND THE UNITED NATIONS SDG3

PAEDIATRICIANS CARING FOR CHILDREN WITH RARE DISEASES IN EUROPE, FALL 2018

PATIENT SOLIDARITY DAY

HEALTH FOR ALL BEGINS WITH HEALTH LITERACY

EAP GLOBAL WEEK FOR ACTION ON NCDS

PRESS RELEASE: YOUNG EAP SUPPORT FOR STRIKE POLISH YOUNG DOCTORS

IMPROVEMENTS TO EUROPEAN DIRECTIVE RELATED TO MARKETING OF UNHEALTHY FOOD AND ALCOHOL TO MINORS

BREXIT AND THE EUROPEAN MEDICAL PROFESSION. LETTER TO EU JANUARY 2017

EAP ON CHILDHOOD TUBERCULOSIS

EAP LETTER TO EUROPEAN COUNCIL PRESIDENT ABOUT EUROPEAN REFERENCE NETWORKS

EAP LETTER TO MEMBERS OF EUROPEAN PARLIAMENT ON EUROPEAN CHILD GUARANTEE

EAP LETTER TO EUROPEAN PARLIAMENT ENVI COMMITTEE

3 STEPS TOWARD HEALTHIER MARKETING IN EU – PRESS RELEASE

PRESS RELEASE NO-3 (JANUARY 2016)

PRESS RELEASE NO-2 (NOVEMBER, 2015)

PRESS RELEASE NO-1 (OCTOBER, 2015)

Don't Wait Any Longer.
Sign up to receive our News!

Share This